Pharmacological treatment for connective tissue disease-associated interstitial lung involvement: Protocol for an overview of systematic reviews and meta-analyses.
<h4>Background</h4>Interstitial lung disease (ILD) is the most important pulmonary manifestation of connective tissue diseases (CTDs) since it is associated with high morbidity and mortality. However, there is uncertainty on what constitutes the optimal treatment options from a variety o...
Saved in:
| Main Authors: | Fotini B Karassa, Konstantinos I Bougioukas, Eleftherios Pelechas, Anastasia Skalkou, Evangelia Argyriou, Anna-Bettina Haidich |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0272327 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nebulized Antibiotics for Preventing and Treating Gram-Negative Respiratory Infections in Critically Ill Patients: An Overview of Reviews
by: Marios Karvouniaris, et al.
Published: (2025-04-01) -
Imaging in connective tissue disease-associated interstitial lung disease
by: Praveen P G. Rao, et al.
Published: (2021-01-01) -
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Connective Tissue Disease Associated Interstitial Lung Disease
by: Ju Hyun Oh, et al.
Published: (2025-04-01) -
Connective Tissue Disease‑Associated Interstitial Lung Disease (CTD‑ILD)
by: Cindy Mai
Published: (2024-11-01) -
Lung transplantation in connective tissue disease associated interstitial lung disease
by: Srinivas Rajagopala, et al.
Published: (2021-01-01)